Dr. Bessudo is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1510 E Herndon Ave
Ste 310
Fresno, CA 93720- Is this information wrong?
Education & Training
- Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1991 - 1992
- Aurora Health CareResidency, Internal Medicine, 1989 - 1991
- Universidad Nacional Autonoma de MexicoClass of 1989
Certifications & Licensure
- CA State Medical License 1991 - 2025
- WI State Medical License 1990 - 1991
Awards, Honors, & Recognition
- Top MD Consumers Checkbook
- Super Doctor SuperDoctors.com
Clinical Trials
- Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia. Start of enrollment: 2003 Jan 01
- Study of PEGPH20 With Initial Dexamethasone Premedication Given Intravenously to Patients With Advanced Solid Tumors Start of enrollment: 2010 Jul 01
- Pomalidomide, Dexamethasone and Pegylated Liposomal Doxorubicin for Relapsed/Refractory Multiple Myeloma Start of enrollment: 2012 Feb 01
- Join now to see all
Publications & Presentations
PubMed
- BETA prime: a first-in-man phase 1 study of AdAPT-001, an armed oncolytic adenovirus for solid tumors.Conley, A., Roland, C., Bessudo, A., Gastman, B., Villaflor, V., Larson, C., Reid, T., Caroen, S., Oronsky, B., Stirn, M., Williams, J., Burbano, E., Coyle, A., Barve,...> ;Cancer Gene Therapy. 2023 Dec 25
- 1 citationsEfficacy and Safety of Replacing Lenalidomide with Pomalidomide for Patients with Multiple Myeloma Refractory to a Lenalidomide-Containing Combination Regimen.Jonathan Afari, Tanya M Spektor, Carley Turner, Alexa Cohen, Alberto Bessudo, Haresh Jhangiani, Nashat Gabrail, Samir Kubba, Jeffrey D Neidhart, Shahrooz Eshaghian, Re...> ;Experimental Hematology. 2022 Oct 1
- 6 citationsBETA PRIME: Phase I study of AdAPT-001 as monotherapy and combined with a checkpoint inhibitor in superficially accessible, treatment-refractory solid tumors.Santosh Kesari, Alberto Bessudo, Brian R Gastman, Anthony P Conley, Victoria M Villaflor, Lisle M Nabell, DeLisa Madere, Emma Chacon, Christina Spencer, Li Li, Christo...> ;Future Oncology. 2022 Sep 1
- Join now to see all
Press Mentions
- Laekna Therapeutics Reported Positive Results in Two Clinical Studies for the Treatment of Various Stages of Prostate Cancer at the ESMO CongressSeptember 16th, 2021
- VerdePharmHealth Signs Exclusive Partnership Agreement with HAI Health for Oncologist-Formulated Medical Cannabis Product LineJune 23rd, 2020
Professional Memberships
- Member
Hospital Affiliations
- Santa Clara Valley Medical CenterSan Jose, California
- Fallbrook HospitalFallbrook, California
- Palomar Medical Center EscondidoEscondido, California
- Scripps Memorial Hospital-La JollaLa Jolla, California
- Tri-City Medical CenterOceanside, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: